Aveanna Healthcare Holdings Inc.
NASDAQ:AVAHMedical - Care Facilities
+$0.10 today
- Market cap
- $2.37B
- Beta
- 1.93
- P/E (TTM)
- 6.3
- EPS (TTM)
- $1.22
Volume 2.12M
Average 1.52M
AVAH Gross Profit
Revenue minus cost of revenue: what remains to cover operating expenses after paying for what was sold.
Aveanna Healthcare Holdings Inc.NASDAQ: AVAH
Gross Profit · Q3 FY2026 · quarter ended Oct 2026
Gross profit grows in line with its trailing trend
Q3 FY2026 gross profit of $226.77M rose 13.3% year over year, ahead of the +12.0% change in trailing-twelve-month gross profit. Sequentially, it rose 3.8% from the prior quarter. Over 3 fiscal years it compounded at +13.3% a year.
Context
- Gross profit amounted to 33.1% of revenue in FY2025, up 1.7 pp from a year earlier.
- Gross profit increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +13.3% holds above the trailing-twelve-month pace of +12.0%.
Sources:Income StatementText generated from reported figures; not investment advice.
Gross Profit history
USD · from the income statement
- Latest · FY2025
- 805.15M USD
- Year-over-year change
- +26.7%
- 4-year CAGR
- +10.4%
| Period | Period end | Gross Profit | YoY change |
|---|---|---|---|
| FY2025 | 2026-01-03 | 805.15M | +26.7% |
| FY2024 | 2024-12-28 | 635.54M | +6.7% |
| FY2023 | 2023-12-31 | 595.43M | +7.6% |
| FY2022 | 2022-12-31 | 553.23M | +2.0% |
| FY2021 | 2021-12-31 | 542.4M | — |
Gross Profit vs competitors
How AVAH compares with its peers on the latest reported figures
- AVAH's LTM Oct 2026 gross profit of $858.25M is the 3rd highest of the 7 companies compared; the peer median is $633.86M.
- Its year-over-year change of +12.0% is the 5th highest of 7, against a peer median of +14.2%.
- Gross profit amounts to 32.1% of revenue for AVAH, versus a peer median of 31.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $2.72B | +13.3% | +13.5% | 43.9% | |
| LTM Sep 2026 | $1.06B | +3.7% | +5.6% | 18.5% | |
| LTM Oct 2026 | $858.25M | +12.0% | +13.3% | 32.1% | |
| LTM Jun 2026 | $789.96M | -6.5% | -0.3% | 30.4% | |
| LTM Jun 2026 | $477.75M | +15.1% | +15.5% | 32.4% | |
| LTM Mar 2026 | $164.27M | +20.2% | +22.4% | 57.3% | |
| LTM Mar 2026 | $151.28M | +47.4% | +27.9% | 14.8% | |
| Peer median (excluding AVAH) | $633.86M | +14.2% | +14.5% | 31.4% | |
Competitors are the stored peer set for AVAH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Jan 2026 |
|---|---|---|---|---|---|
| Revenue | 1.68B | 1.79B | 1.9B | 2.02B | 2.43B |
| Cost of Revenue | 1.14B | 1.23B | 1.3B | 1.39B | 1.63B |
| Gross Profit | 542.4M | 553.23M | 595.43M | 635.54M | 805.15M |
| Gross Margin | 32.3% | 30.9% | 31.4% | 31.4% | 33.1% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 419.64M | 483.95M | 464.74M | 470.47M | 526.74M |
| Operating Expenses | 578.52M | 1.2B | 587.36M | 495.76M | 539.77M |
| Depreciation & Amortization | 35.39M | 38.82M | 30.1M | 31.16M | 28.22M |
| EBITDA | (17.96M) | (525.06M) | 39.17M | 187.38M | 279.02M |
| EBITDA Margin | -1.1% | -29.4% | 2.1% | 9.3% | 11.5% |
| Operating Income | (36.11M) | (642.28M) | 8.07M | 139.79M | 265.38M |
| Operating Margin | -2.2% | -35.9% | 0.4% | 6.9% | 10.9% |
| Interest Income | 253K | 679K | 327K | 498K | 2.83M |
| Interest Expense | 68.93M | 107.72M | 153.25M | 156.6M | 140.09M |
| Other Income / Expenses | (77.47M) | (21.54M) | (147.07M) | (134.72M) | (158.43M) |
| Income Before Tax | (113.58M) | (663.81M) | (139M) | 5.07M | 106.95M |
| Pre-Tax Margin | -6.8% | -37.1% | -7.3% | 0.3% | 4.4% |
| Income Tax Expense | 3.47M | (1.78M) | (4.47M) | 16M | (118.09M) |
| Net Income | (117.04M) | (662.03M) | (134.52M) | (10.93M) | 225.03M |
| Net Margin | -7.0% | -37.0% | -7.1% | -0.5% | 9.2% |
| EPS (Basic) | (0.63) | (3.57) | (0.71) | (0.06) | 1.10 |
| EPS (Diluted) | (0.63) | (3.57) | (0.71) | (0.06) | 1.05 |
| Weighted Avg Shares | 184.73M | 185.55M | 189.96M | 192.89M | 203.53M |
| Weighted Avg Shares (Diluted) | 184.73M | 185.55M | 189.96M | 192.89M | 214.98M |
Aveanna Healthcare Holdings Inc.
NASDAQ:AVAH
Intrinsic Alpha fair value
Locked
Current Price
$10.85
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.